Xequel Bio, Inc.
Records under this name other than the patents Xequel Bio, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
Showing 1 to 1 of 1 · Back to Xequel Bio, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,846,605 | Formulations and Methods of Use for Alpha Connexin C-Terminal (ACT) Peptides Lapsed on the fee record Ended Sep 30, 2026 · Medium confidence | Lapsed on the fee record | Ended Sep 30, 2026 | Medium confidence |